HDAC inhibitor IV is a cell-permeable pimeloylanilide compound that acts as a FXN- (frataxin gene) specific HDAC (histone deacetylase) inhibitor.
Product Name: HDAC inhibitor IV|Cat No.:DC8828|CAS: 537034-15-4|Other names: Histone Deacetylase Inhibitor IV|MW: 325.4|C19H23N3O2
HDAC inhibitor IV is a cell-permeable pimeloylanilide compound that acts as a FXN- (frataxin gene) specific HDAC (histone deacetylase) inhibitor. Reverses the silencing of FXN transcription in FRDA (Friedreich's ataxia) cells (~3-fold increase of FXN mRNA at 5 µM in primary FRDA lymphocytes and ~3-fold frataxin expression in FRDA cell line at 2.5 µM) due to hypoacetylation of histones H3 and H4 by increasing acetylation at H3K14, H4K5 and H4K12, without significant changes in acetylation at H3K9, H4K8 and H4K16. In comparison, Trichostatin-A and SAHA, two other commonly used HDAC inhibitors, exhibit no effect on FXN transcription.
For research only, not for human use!
没有评论:
发表评论